Everyday employees come to work in pain. Their pain not only impacts their day to day, but their pain impacts the entire health plan as other conditions such as diabetes, weight, and stress, for example, get worse. As an alternative to traditional surgeries, Regenexx utilizes a needle-based approach using the patient's own cells from their blood. To tell us more about Regenexx's approach, Mark Testa, Executive Vice President; Regenexx, joins the show to display the impact Regenexx can have - including how they've been validated as generating 49% cost savings across the board by replacing up to 70% of elective orthopedic surgeries.